What does CUSIP 24823R105 represent in this 13F holders report?

CUSIP 24823R105 is the security identifier for DNLI - Denali Therapeutics Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held DNLI - Denali Therapeutics Inc. - Common Stock in Q2 2020?

142 institutional investors reported DNLI - Denali Therapeutics Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Denali Therapeutics Inc. - Common Stock (DNLI)

CUSIP: 24823R105

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Stock
Total 13F shares: 82,768,394
Total 13F value: $2,001,309,869
Share change: +2,336,348
Put/Call ratio: 39%
SEC-reported price per share: $24.18
Number of holders: 142
Value change: +$63,425,607
Number of buys: 83
Number of sells: 46
Shares outstanding: 159,469,733

Security key

24823R105

Report period

Q2 2020

Institutions

142

Top holders

DNLI full security history Ownership snapshot Full 13F holder table Denali Therapeutics Inc. SEC filings Denali Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DNLI - Denali Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Crestline Management, L.P.

Disclosed value leader

Crestline Management, L.P.

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 9.8% Showing 1-6 of 15 holder rows.

Quick read

Crestline Management, L.P. leads the comparable SEC ownership view at 9.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Crestline Management, L.P.'s linked filing trail.

Comparable ownership Top 5

Crestline Management, L.P. 9.8%

BAILLIE GIFFORD & CO 5.7%

Flagship Pioneering, LLC 5%

VANGUARD GROUP INC 4.3%

BlackRock Finance, Inc. 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Crestline Management, L.P.	13F Company 13F	9.8%	$272,591,000 15,567,736 shares	—	31 Mar 2020
BAILLIE GIFFORD & CO	13F Company 13F	5.7%	$159,861,000 9,129,752 shares	—	31 Mar 2020
Flagship Pioneering, LLC	13F Company 13F	5%	$139,734,000 7,980,263 shares	—	31 Mar 2020
VANGUARD GROUP INC	13F Company 13F	4.3%	$120,965,000 6,908,331 shares	—	31 Mar 2020
BlackRock Finance, Inc.	13F Company 13F	3.3%	$92,213,000 5,266,356 shares	—	31 Mar 2020
FMR LLC	13F Company 13F	3.3%	$91,501,000 5,225,670 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

142

82,768,394

Rows available

142

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

127

Q2 2020 holders

142

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %